The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?
Abstract
This minireview gets an insight into recent findings on the implication of IL‐1ra and its gene polymorphism in diabetes and obesity, discusses the potential dual effects of IL‐1ra observed in different models, and comments on future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 2×
“its immunomodulatory and/or metabolic activities as described in sepsis or inflammatory disorders [2].”
BackgroundRotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Horai, R., Asano, M., Sudo, K., Kanuka, H., Suzuki, M., Nishihara, M., Takahashi, M., & Iwakura, Y. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1463 · Cited by 611
Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8351 · Cited by 287
Decreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice
Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J. H., & Meier, C. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3503 · Cited by 114 · cited 4×
“cient to block IL-1 activity at a systemic and/or local levels [53].”
BackgroundMethodInfluentialSomm, E., Cettour-Rose, P., Asensio, C., Charollais, A., Klein, M., Theander-Carrillo, C., Juge-Aubry, C. E., Dayer, J. M., Nicklin, M. J. H., Meda, P., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0046-x · Cited by 111
Cited by
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Nilsson, E., Jansson, P. A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M. K., Poulsen, P., Ribel-Madsen, R., Pedersen, N. L., Almgren, P., et al. (2014) · Diabetes · doi:10.2337/db13-1459 · Cited by 391
Diabetes Treatment — Bridging the Divide
Rother, K. I. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078030 · Cited by 370
Insulin signalling mechanisms for triacylglycerol storage
Czech, M. P., Tencerova, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 276
Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance
Kleemann, R., van Erk, M., Verschuren, L., van den Hoek, A. M., Koek, M., Wielinga, P. Y., Jie, A., Pellis, L., Bobeldijk-Pastorova, I., Kelder, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008817 · Cited by 146
Metadata
- Authors
- Perrier, S., Darakhshan, F., & Hajduch, E.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2006-11-03
- Volume
- 580
- Issue
- 27
- Pages
- 6289-6294
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2086068975
- Cited by
- 173
- References
- 6
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? https://app.cochat.ai/papers/10.1016/j.febslet.2006.10.061
- The paper
- Perrier, S., Darakhshan, F., & Hajduch, E. (2006). IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Letters. https://doi.org/10.1016/j.febslet.2006.10.061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.